help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richel, D. J.
Right arrow Articles by Kluin, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richel, D. J.
Right arrow Articles by Kluin, P. M.

American Journal of Pathology, Vol 136, 1093-1099, Copyright © 1990 by American Society for Investigative Pathology


REGULAR ARTICLES

Epstein-Barr virus in a CD8-positive T-cell lymphoma

DJ Richel, JM Lepoutre, JG Kapsenberg, EC Ooms, WR Boom, CA Boucher and PM Kluin
Department of Clinical Hematology, University of Leiden, The Netherlands.

In contrast to its role in B-lymphomagenesis, Epstein-Barr Virus (EBV) only incidentally has been associated with T-cell lymphomas. In the present report we describe a fourth patient with EBV-related T-cell lymphoma. The patient presented with an angio-immunoblastic lymphadenopathy (AILD)-like T-cell lymphoma. Serology was compatible with chronic Epstein-Barr (EBV) infection. After a 1-year period of waxing and waning lymphadenopathy, this lymphoma evolved to an aggressive CD8+ Immunoblastic T-cell lymphoma. A relationship with the chronic EBV infection was indicated by the finding of EBV genome in the tumor tissue by Southern blot analysis. Moreover, EBV nuclear antigen (EBNA) was detected in situ within individually defined CD8+ tumor cells by two-color immunofluorescence. Two alternative possibilities, namely that EBV primarily played a role in lymphomagenesis of the AILD- like T-cell lymphoma or that the virus was an additional oncogenic event in the final process of tumor progression to the immunoblastic lymphoma, are discussed.


This article has been cited by other articles:


Home page
JCOHome page
P. Went, C. Agostinelli, A. Gallamini, P. P. Piccaluga, S. Ascani, E. Sabattini, F. Bacci, B. Falini, T. Motta, M. Paulli, et al.
Marker Expression in Peripheral T-Cell Lymphoma: A Proposed Clinical-Pathologic Prognostic Score
J. Clin. Oncol., June 1, 2006; 24(16): 2472 - 2479.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
E. Geissinger, I. Bonzheim, L. Krenacs, S. Roth, P. Strobel, G. Ott, P. Reimer, M. Wilhelm, H. K. Muller-Hermelink, and T. Rudiger
Identification of the Tumor Cells in Peripheral T-Cell Lymphomas by Combined Polymerase Chain Reaction-Based T-Cell Receptor {beta} Spectrotyping and Immunohistological Detection with T-Cell Receptor {beta} Chain Variable Region Segment-Specific Antibodies
J. Mol. Diagn., October 1, 2005; 7(4): 455 - 464.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. G. Ferrari, E. D. Rivadeneira, R. Jarrett, L. Stevceva, S. Takemoto, P. Markham, and G. Franchini
HVMNE, a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits
Blood, October 1, 2001; 98(7): 2193 - 2199.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Groux, F. Cottrez, C. Montpellier, B. Quatannens, J. Coll, D. Stehelin, and C. Auriault
Isolation and Characterization of Transformed Human T-Cell Lines Infected by Epstein-Barr Virus
Blood, June 15, 1997; 89(12): 4521 - 4530.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Society for Investigative Pathology.